Moreover, editing events of these genes have been associated with cancer progression (e.g., AZIN1 [16], COPA [61], CCNI [62], and FLNB [63]) or neurological disorders (e.g., GRIK2 and GRIA2–4) [52]. This evidence concerns the gene CCNI and cancer.